Design and In-vitro characterization of levobunolol hydrochloride occuserts with special reference to glaucoma treatment

Indian Journal of Pharmaceutical Education and Research

Volumn 46, Issue 3, 2012, Pages 265-269

  Pandey, Ashish ^a   Mali, Prashant Y ^b   Sachdeva, Dinesh ^c   Ramesh, Ravada ^d  

^a GURUKUL KANGRI UNIVERSITY   (India)

^b Adama University   (Ethiopia)

^c Rajasthan State Pharmacy Council   (India)

^d Dr H L T College of Pharmacy   (India)

Author keywords

Glaucoma; In vitro characterization; Levobunolol HCL; Occusert

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE; LEVOBUNOLOL; METHYLCELLULOSE; PLASTICIZER; POVIDONE;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; DRUG DESIGN; DRUG SOLUBILITY; GLAUCOMA; HUMAN; HYDROGEN BOND; IN VITRO STUDY; INTRAOCULAR PRESSURE; MOISTURE; PHYSICAL CHEMISTRY; PROCESS OPTIMIZATION; SURFACE PROPERTY; TABLET THICKNESS; TENSILE STRENGTH;

EID: 84867693917     PISSN: 00195464     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Imam S, Bansal A, Bushetti SS, Singh Aand Chopra H. Novel ocular dosage form in the treatment of glaucoma. The Pharma Res 2009; 01:72-81.
2. Saxena R, Prakash J, Mathur P and Gupta SK. Pharmacotherapy of Glaucoma. Indian J Pharmacol 2002; 34:71-85.
3. BETAGAN-Levobunolol hydrochloride solution, Allergan Inc. U.S.A (2005), Available from URL: http://www.dailymed.nlm.nih,govdailymeddruglnfo.cfmid=6973.
4. Pandey A, Mali PY, Sachdeva D, Patel DK and Ravda R. Development and optimization of levobunolol hydrochloride In-Situ gel for glaucoma treatment. IntJ Pharma BioArchiv 2010; 1(2):134-9.
5. Manikandar VM, Narkilli SN, Prabaharan P and Karthikayini M. Formulation and evaluation of ciprofloxacin hydrochloride occuserts. The Eastern Pharmacist 1998; 101 (487):131.
6. Gupta A, Sharma SK, Ahuja M. In vitro and in vivo evaluation of gellan based ocular inserts of phenylephrine. Acta Pharma Sci 2007;49:55-63.
7. Saisivam S, Muthumanikandar RV and Nagarajan M. Design and evaluation of ciprofloxacin HCI occuserts. Indian J Pharma Sci 1999; 61:34-38.
8. Manvi FV, Soppimath KS and Gadad AP. Development and evaluation of timolol maleate ocular inserts. Indian Drugs 1997; 34:264-8.
9. Sultana Y, Aquil M, Ali A. Ocular insert for controlled delivery of pefloxacin mesylate: preparation and evaluation. Acta Pharma Sci 2005;55:305-14.
10. Aie A, Sharma SN. Fabrication of a through flowapparatusfor in-vito determination of drug from ophthalmic preparations. Indian Drugs 1991;29:157-60.
11. Murthy SN. Biodegradable polymers matrix based occuserts of diclofenacsodium. Indian Drugs 1997; 34:336-338.
12. Dhanaraju MD, Sivakumar VR and Bhaskar K. Bioadhesive occuserts matrix for ophthalmic administration of ciprofloxacin HCI. Indian Drugs 2002; 39:222-4.
13. Murthy SN, Hiremath SR. Biodegradable polymers matrix based occuserts. Int J Pharma Excip 2002; 34-7.
14. Mundada AS, Shrikhande BK. Design and evaluation of soluble ophthalmic insert for controlled release of ciprofloxacin hydrochloride. Drug Dev Ind Pharm 2006; 32:443-8.
15. Semalty M, Semalty A and Kumar G. Formulation and characterization of mucoadhesive buccal film of glipizide, Indian J Pharma Sci 2008; 70:61-65.
16. Trindade MAG, Cunha PAC and Araujo TA. Interaction study of moxifloxacin with Cu(ll) ion using square-wave voltammetry and its application in the determination in tablets. Ecl Quim 2006; 31:31-8.
17. Mundada A, Shrikhande BK. Formulation and evaluation of ciprofloxacin hydrochloride soluble ocular insert. Current Eye Res 2008;33:469-75.
18. Sreenivas SA, Hiremanth SP and Godbole AM. Ofloxacin ocular inserts: Design, formulation and evaluation. Indian J Pharm Tech 2006;5:159-62.
19. Pandey A, Mali PY, Sachdeva D, Ravda R. Characterization of best optimized levobunolol hydrochloride occusert formulations with special reference to glaucoma treatment. Indain J Pharm Edu Res 2011;45(4):326-32.